Skip to main content

Table 1 Demographic, anthropometric and clinical characteristics of all participants

From: Free fatty acids profile among lean, overweight and obese non-alcoholic fatty liver disease patients: a case – control study

 

HC (n = 66)

NAFLD Patients

 

Lean (n = 67)

Overweight (n = 55)

Obese (n = 48)

Sex (m/f)

42/24

41/26

36/19

30/18

Age (y)

40.03 ± 10.17

48.38 ± 12.13a

47.74 ± 13.30a

49.18 ± 12.25a

BMI (kg/m 2)

20.41 ± 2.06

22.58 ± 0.75a

26.19 ± 1.03ab

29.49 ± 2.17abc

WC (cm)

78.23 ± 9.11

88.25 ± 6.03a

93.51 ± 7.79ab

98.06 ± 9.65ab

Body fat (%)

20.23 ± 4.82

25.25 ± 4.93a

30.79 ± 3.90ab

31.32 ± 3.07ab

SBP (mmHg)

114.74 ± 10.44

131.91 ± 19.92a

130.87 ± 14.90a

126.44 ± 10.55a

DBP (mmHg)

79.42 ± 7.93

84.75 ± 7.57a

88.30 ± 8.72a

85.94 ± 6.53a

FBG (mmol/L)

5.28 ± 0.46

6.22 ± 1.66a

5.54 ± 0.70b

6.28 ± 1.33ac

Fasting insulin (IU/ml)

5.79 ± 2.77

8.16 ± 3.14a

8.91 ± 4.35a

11.89 ± 5.76abc

HOMA-IR

1.38 ± 0.74

2.33 ± 1.15a

2.18 ± 1.10a

3.59 ± 2.82abc

TC (mmol/L)

4.40 ± 0.66

5.31 ± 0.93a

5.19 ± 0.77a

5.35 ± 1.07a

TG (mmol/L)

0.86 ± 0.30

1.68 ± 0.66a

1.87 ± 1.13a

2.17 ± 1.27ab

HDL-C (mmol/L)

1.69 ± 0.31

1.51 ± 0.27a

1.54 ± 0.36a

1.31 ± 0.26abc

LDL-C (mmol/L)

2.50 ± 0.52

3.29 ± 0.78a

3.20 ± 0.73a

3.30 ± 0.86a

ALT (U/L)

15.21 ± 7.55

24.06 ± 10.92a

25.11 ± 15.84a

28.11 ± 14.94a

AST (U/L)

18.65 ± 4.45

22.21 ± 6.10a

23.92 ± 7.93a

22.15 ± 6.09a

ALP (U/L)

64.56 ± 15.87

72.88 ± 17.96a

67.61 ± 15.54

69.19 ± 19.34

GGT (U/L)

19.66 ± 12.93

46.32 ± 40.05a

45.84 ± 43.95a

48.48 ± 24.75a

  1. a P < 0.05, when compared with healthy controls;
  2. b P < 0.05, when compared with Lean-NAFLD group;
  3. c P < 0.05, when compared with overweight-NAFLD group